These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19618076)
1. Evaluation of the agreement between clinical and laboratorial exams in the diagnosis of leprosy. Teixeira AC; Cruvinel DL; Roma FR; Luppino LF; Resende LH; Sousa Td; Bührer-Sékula S; Goulart IM Rev Soc Bras Med Trop; 2008; 41 Suppl 2():48-55. PubMed ID: 19618076 [TBL] [Abstract][Full Text] [Related]
2. The influence of ML Flow test in leprosy classification. Grossi MA; Leboeuf MA; Andrade AR; Lyon S; Antunes CM; Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():34-8. PubMed ID: 19618073 [TBL] [Abstract][Full Text] [Related]
3. Leprosy serology (ML Flow test) in borderline leprosy patients classified as paucibacillary by counting cutaneous lesions: an useful tool. Barreto JA; Nogueira ME; Diorio SM; Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():45-7. PubMed ID: 19618075 [TBL] [Abstract][Full Text] [Related]
4. The value of IgM antibodies to PGL-I in the diagnosis of leprosy. Lefford MJ; Hunegnaw M; Siwik E Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367 [TBL] [Abstract][Full Text] [Related]
5. Association of the ML Flow serologic test to slit skin smear. Lyon S; Castorina da Silva R; Lyon AC; Grossi MA; Lyon SH; Azevedo Mde L; Bührer-Sékula S; Rocha MO Rev Soc Bras Med Trop; 2008; 41 Suppl 2():23-6. PubMed ID: 19618071 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for ML Flow seropositivity in leprosy patients. Grossi MA; Leboeuf MA; Andrade AR; Bührer-Sékula S; Antunes CM Rev Soc Bras Med Trop; 2008; 41 Suppl 2():39-44. PubMed ID: 19618074 [TBL] [Abstract][Full Text] [Related]
7. A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil. Lyon S; Lyon AC; Da Silva RC; Grossi MA; Lyon SH; Bührer-Sékula S; Rocha MO Lepr Rev; 2008 Jun; 79(2):162-70. PubMed ID: 18711938 [TBL] [Abstract][Full Text] [Related]
9. Leprosy serology using PGL-I: a systematic review. Moura RS; Calado KL; Oliveira ML; Bührer-Sékula S Rev Soc Bras Med Trop; 2008; 41 Suppl 2():11-8. PubMed ID: 19618069 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier. Moura RS; Penna GO; Fujiwara T; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Cardoso LP; Stefani MM; Bührer-Sékula S J Immunol Methods; 2014 Oct; 412():35-41. PubMed ID: 24983877 [TBL] [Abstract][Full Text] [Related]
11. The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: a field evaluation. Bührer-Sekula S; Cunha MG; Ferreira WA; Klatser PR FEMS Immunol Med Microbiol; 1998 Jul; 21(3):197-201. PubMed ID: 9718209 [TBL] [Abstract][Full Text] [Related]
12. Anti M. leprae IgM antibody determination by ultramicroimmunoenzymatic (UMELISA HANSEN) for the diagnosis and monitoring leprosy. Torrella A; Solis RL; Perez E; Medina Y; Kerguelen C; Olaya P Rev Inst Med Trop Sao Paulo; 1998; 40(3):177-81. PubMed ID: 9830732 [TBL] [Abstract][Full Text] [Related]
13. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients? Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693 [TBL] [Abstract][Full Text] [Related]
14. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654 [TBL] [Abstract][Full Text] [Related]
16. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas. Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070 [TBL] [Abstract][Full Text] [Related]
17. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients. Cree IA; Smith WC; Beck JS Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317 [TBL] [Abstract][Full Text] [Related]
18. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099 [TBL] [Abstract][Full Text] [Related]
20. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories. Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]